Mackay Shields LLC’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-36,585
| Closed | -$9.55M | – | 688 |
|
|
2022
Q1 | $9.55M | Sell |
36,585
-1,398
| -4% | -$365K | 0.08% | 228 |
|
|
2021
Q4 | $8.34M | Sell |
37,983
-1,594
| -4% | -$350K | 0.07% | 260 |
|
|
2021
Q3 | $7.18M | Sell |
39,577
-1,146
| -3% | -$208K | 0.07% | 260 |
|
|
2021
Q2 | $8.21M | Sell |
40,723
-9,706
| -19% | -$1.96M | 0.08% | 242 |
|
|
2021
Q1 | $10.8M | Sell |
50,429
-8,195
| -14% | -$1.76M | 0.08% | 265 |
|
|
2020
Q4 | $13.9M | Sell |
58,624
-34,235
| -37% | -$8.09M | 0.1% | 239 |
|
|
2020
Q3 | $25.3M | Buy |
92,859
+47,931
| +107% | +$13M | 0.17% | 124 |
|
|
2020
Q2 | $13M | Sell |
44,928
-33,669
| -43% | -$9.77M | 0.1% | 228 |
|
|
2020
Q1 | $18.7M | Buy |
78,597
+34,837
| +80% | +$8.29M | 0.17% | 146 |
|
|
2019
Q4 | $9.58M | Sell |
43,760
-3,785
| -8% | -$829K | 0.07% | 337 |
|
|
2019
Q3 | $8.06M | Buy |
47,545
+2,944
| +7% | +$499K | 0.05% | 389 |
|
|
2019
Q2 | $8.18M | Buy |
44,601
+338
| +0.8% | +$62K | 0.06% | 391 |
|
|
2019
Q1 | $8.14M | Buy |
44,263
+5,568
| +14% | +$1.02M | 0.06% | 379 |
|
|
2018
Q4 | $6.41M | Sell |
38,695
-2,067
| -5% | -$343K | 0.05% | 418 |
|
|
2018
Q3 | $7.86M | Sell |
40,762
-480
| -1% | -$92.5K | 0.06% | 358 |
|
|
2018
Q2 | $7.01M | Sell |
41,242
-1,326
| -3% | -$225K | 0.05% | 413 |
|
|
2018
Q1 | $6.94M | Buy |
+42,568
| New | +$6.94M | 0.04% | 438 |
|